• PHP15 - NEW TREATMENT METHODS AND REIMBURSEMENT- EXPERIENCES IN GERMANY 2018

    Oct 1, 2018, 00:00

  • PHP102 - ARE SPECIFIC METHODOLOGICAL FRAMEWORKS REQUIRED FOR THE ECONOMIC EVALUATION OF GENE THERAPIES?

    Oct 1, 2018, 00:00

  • PIN13 - THE INCIDENCE OF SURGICAL SITE INFECTION IN POLAND

    Oct 1, 2018, 00:00

  • PHP258 - DEVELOPMENT OF A REAL WORLD EVIDENCE STUDY DESIGN TOOL

    Oct 1, 2018, 00:00

  • PHP11 - HOW TO RESOLVE ISSUES EXPERIENCED BY PATIENTS IN EARLY PHASE DEVELOPMENT OF PHARMACEUTICAL PRODUCTS

    Oct 1, 2018, 00:00

  • PCN118 - THE BURDEN OF CANCER IN SPAIN

    Oct 1, 2018, 00:00

  • PHP64 - ALLOWABILITY OF OUTCOMES-BASED RISK-SHARING SCHEMES IN RUSSIA WITHIN CURRENT LEGISLATIVE HURDLES

    Oct 1, 2018, 00:00

  • PSY189 - TREATMENT GUIDELINE INCLUDING THE HEALTH ECONOMIC EVALUATIONS OF BIOLOGIC DRUGS USED FOR PSORIATIC ARTHRITIS- PICOSTEPS, SYSTEMATIC LITERATURE REVIEW, APPLICABILITY EVALUATION AND LEVEL OF EVIDENCE EVALUATION

    Oct 1, 2018, 00:00

  • PDB93 - IMPACT OF CARDIOVASCULAR DISEASE ON HEALTHCARE RESOURCE UTILIZATION IN PATIENTS WITH TYPE 2 DIABETES IN A REAL WORLD SETTING

    Oct 1, 2018, 00:00

  • PSS48 - PARENTS’ BELIEFS AND KNOWLEDGE ABOUT THE MANAGEMENT OF OTITIS MEDIA IN UNAIZAH, SAUDIARABIA- A QUALITATIVE STUDY

    Oct 1, 2018, 00:00

  • PIN55 - COST-EFFECTIVENESS ANALYSIS OF INFANT FORMULA SUPPLEMENTED WITH HUMAN MILK OLIGOSACCHARIDE (HMO) IN THE PREVENTION OF LOWER RESPIRATORY TRACT INFECTIONS IN MEXICO AND CHINA

    Oct 1, 2018, 00:00

  • PIN87 - PHYSICIAN PREFERENCES FOR THE TREATMENT OF CHRONIC HEPATITIS C VIRUS INFECTION- AN ADAPTIVE CONJOINT ANALYSIS

    Oct 1, 2018, 00:00

  • PSS35 - SECUKINUMAB VERSUS USTEKINUMAB FOR THE TREATMENT OF PSORIASIS- A 52-WEEK COST PER RESPONDER ANALYSIS FROM THE PORTUGUESE PAYER PERSPECTIVE

    Oct 1, 2018, 00:00

  • PIH46 - ANALYSING THE ATTITUDE OF OLD AGE HOME RESIDENTS ON POLYPHARMACY AND DEPRESCRIBING OF MEDICATIONS IN MANGALORE, KARNATAKA.

    Oct 1, 2018, 00:00

  • PMH55 - A COMPARISON OF PATIENTS PRESCRIBED ANTIPSYCHOTICS FOR PARKINSON’S DISEASE WITH PSYCHOSIS USING ADMINISTRATIVE CLAIMS DATA FROM A LARGE U.S. INSURER

    Oct 1, 2018, 00:00

  • PCN163 - COST-EFFECTIVENESS OF ADD-ON PERTUZUMAB COMBINED WITH TRASTUZUMAB AND DOCETAXEL VERSUS PLACEBO AS TREATMENT OF HER-2 POSITIVE METASTATIC BREAST CANCER IN CZECH REPUBLIC

    Oct 1, 2018, 00:00

  • PIN56 - COST-EFFECTIVENESS OF VARICELLA AND HERPES ZOSTER VACCINATION IN THE SWEDISH POPULATION

    Oct 1, 2018, 00:00

  • PND125 - THE ASSOCIATION BETWEEN UTILITIES AND DISEASE SEVERITY FOR PARKINSON’S DISEASE- A SYSTEMATIC LITERATURE REVIEW

    Oct 1, 2018, 00:00

  • PMS103 - IMPACT OF PHYSICAL FUNCTIONING ON THE QUALITY OF LIFE AFTER TOTAL KNEE REPLACEMENT

    Oct 1, 2018, 00:00

  • PCN247 - TREATMENT PATTERNS IN RECURRENT OR METASTATIC SQUAMOUS CELL CARCINOMA OF HEAD AND NECK (R/M SCCHN) POST PLATINUM-BASED THERAPY (PPBT) IN THE IMMUNO-ONCOLOGY (IO) ERA

    Oct 1, 2018, 00:00

  • PCN274 - TIME TO PRICE CHANGE FOLLOWING HTA DECISIONS

    Oct 1, 2018, 00:00

  • PUK1 - DR RAJA AHSAN AFTAB

    Oct 1, 2018, 00:00

  • PRS38 - COST-CONSEQUENCE ANALYSIS OF FLUTICASONE FUROATE/VILANTEROL FOR ASTHMA MANAGEMENT IN SPAIN- AN ANALYSIS BASED ON THE SALFORD LUNG STUDY IN ASTHMA

    Oct 1, 2018, 00:00

  • PHP331 - IS IT ENOUGH TO HAVE IT IN THE VACCINATION PROGRAMME? AN EMPIRICAL ANALYSIS OF THE FACTORS THAT AFFECT INFLUENZA VACCINATION UPTAKE IN ADULTS IN GREECE

    Oct 1, 2018, 00:00

  • PSS67 - UNDERSTANDING THE PATIENT EXPERIENCE OF PRESBYOPIA AND IDENTIFICATION OF PATIENT-REPORTED OUTCOME ASSESSMENTS- A LITERATURE REVIEW

    Oct 1, 2018, 00:00

  • PCP15 - WHY EUROPEAN CROSS-BORDER INITIATIVES ON DRUG PROCUREMENT MAY FAIL?

    Oct 1, 2018, 00:00

  • PMS19 - A BUDGET IMPACT ANALYSIS OF INTRODUCING A FORCED TREATMENT PATHWAY USING THE LOWEST PRICED ANTI-TUMOR NECROSIS FACTOR AGENT FOR RHEUMATOID ARTHRITIS AND ANKYLOSING SPONDYLITIS IN THE PHILIPPINES

    Oct 1, 2018, 00:00

  • PCV21 - IMPACT OF GENETIC AND NON-GENETIC FACTORS ON CLOPIDOGREL EFFICACY

    Oct 1, 2018, 00:00

  • PCV131 - IMPACT OF TIMELY INITIATION OF ANTIHYPERTENSIVE MEDICATIONS FOR PATIENTS WITH HYPERTENSION OR ELEVATED BLOOD PRESSURE

    Oct 1, 2018, 00:00

  • PRM127 - ECONOMIC MODELLING CONSIDERATIONS IN RARE DISEASES- A TARGETED REVIEW OF HIGHLY SPECIALISED TECHNOLOGY APPRAISALS

    Oct 1, 2018, 00:00

  • PSY96 - COST-EFFECTIVENESS OF ORIGINATOR ADALIMUMAB IN NON-INFECTIOUS INTERMEDIATE, POSTERIOR AND PAN-UVEITIS FROM A SOCIETAL PERSPECTIVE IN PORTUGAL

    Oct 1, 2018, 00:00

  • PMU38 - REVIEW OF STUDIES REPORTING ACTUAL PRICES FOR MEDICINES

    Oct 1, 2018, 00:00

  • PHP235 - INDIRECT TREATMENT COMPARISONS (ITC) FOR HTA IN EUROPE – UNDERSTANDING REQUIREMENTS FOR INDUSTRY SUBMISSIONS

    Oct 1, 2018, 00:00

  • PRS83 - PATIENT PERSPECTIVE ON MEDICATION ADHERENCE IN ASTHMA- A SYSTEMATIC REVIEW OF THE LITERATURE

    Oct 1, 2018, 00:00

  • PIH29 - DEVELOPMENT OF A DECISION AID PROTOTYPE FOR PARENTS CONSIDERING TUBE FEEDING FOR THEIR CHILDREN

    Oct 1, 2018, 00:00

  • PCN228 - REAL-WORLD USE OF PEMBROLIZUMAB AND NIVOLUMAB FROM CLINICAL TRIALS TO MARKET LAUNCH- WHAT CAN BE LEARNED?

    Oct 1, 2018, 00:00

  • PCN363 - A BEST–WORST SCALING SURVEY OF PREFERENCES OF CURRENT, PAST AND NEVER SMOKERS FOR ADVERSE EFFECTS OF SMOKING IN JAPAN

    Oct 1, 2018, 00:00

  • PHP267 - LANDSCAPE ASSESSMENT OF PROSPECTIVE REAL-WORLD EVIDENCE STUDIES IN EUROPE

    Oct 1, 2018, 00:00

  • PCN275 - HOW DO HTA DECISIONS FOR NEW DISEASE CONDITIONS IMPACT TIME TO PRICE CHANGES?

    Oct 1, 2018, 00:00

  • PRM193 - FROM INDIVIDUAL PATIENT TO POPULATION PREFERENCES- MULTINOMIAL LOGIT MODEL VS DIRICHLET DISTRIBUTION

    Oct 1, 2018, 00:00

  • PCN127 - DIRECT HEALTHCARE COSTS BY TREATMENT AMONG PATIENTS WITH MERKEL CELL CARCINOMA (MCC) IN THE UNITED STATES

    Oct 1, 2018, 00:00

  • PDB5 - EFFECT OF STATINS USAGE ON INCIDENCE OF PERIPHERAL NEUROPATHY AMONG PATIENTS WITH TYPE 2 DIABETES MELLITUS

    Oct 1, 2018, 00:00

  • PRM98 - FACTORS ASSOCIATED WITH THE INCIDENCE OF ONCOLOGY DRUGS SHORTAGES IN THE UNITED STATES (2001-2017)

    Oct 1, 2018, 00:00

  • PSY58 - BUDGET IMPACT ANALYSIS OF EMICIZUMAB IN PEDIATRIC HEMOPHILIA A PATIENTS WITH INHIBITORS IN THE MINISTRY OF HEALTH (MOH), KINGDOM OF SAUDI ARABIA

    Oct 1, 2018, 00:00

  • PSY9 - REAL-WORLD EPIDEMIOLOGY, TREATMENT PATTERNS AND SURVIVAL OF MULTIPLE MYELOMA PATIENTS IN A LARGE NATIONWIDE HEALTH PLAN

    Oct 1, 2018, 00:00

  • PSS57 - TREATMENT OF ATOPIC DERMATITIS IN PORTUGAL- INSIGHTS FROM A PHYSICIANS’ SURVEY

    Oct 1, 2018, 00:00

  • PND67 - ARE NEW PREVENTIVE MIGRAINE DRUGS COST-EFFECTIVE FOR PATIENTS WITH CHRONIC AND EPISODIC MIGRAINE FOR WHOM OTHER PREVENTIVE MEDICATIONS HAD FAILED?

    Oct 1, 2018, 00:00

  • PMU126 - SUBJECTIVE EXPECTATIONS REGARDING FUTURE HEALTH, WELL-BEING AND HEALTHCARE COSTS IN HUNGARY

    Oct 1, 2018, 00:00

  • PMU76 - PATIENT SATISFACTION FROM INSTRUCTIONS OF COLONOSCOPY PREPARATION AND COST ASSESSMENT OF INADEQUATE BOWEL PREPARATION

    Oct 1, 2018, 00:00

  • PGI33 - URSODEOXYCHOLIC ACID TO GALLSTONE DISSOLUTION THERAPY IN ASYMPTOMATIC CHOLELITHIASIS PATIENTS- A SYSTEMATIC REVIEW OF THE EFFICACY AND SAFETY

    Oct 1, 2018, 00:00

  • PRS17 - BUDGET IMPACT ANALYSIS OF THE USE OF UMECLIDINIUM BROMIDE/VILANTEROL 62.5/25 MCG IN THE TREATMENT OF CHRONIC OBSTRUCTIVE PULMONARY DISEASE IN SPAIN

    Oct 1, 2018, 00:00

  • PIH26 - PRACTICE TOWARD ANTIBIOTICS PREPARATION AMONG IRANIAN PARENTS

    Oct 1, 2018, 00:00

  • PDB104 - IMPACT OF DAPAGLIFLOZIN ON REDUCING ECONOMIC BURDEN OF DIABETES IN EGYPT

    Oct 1, 2018, 00:00

  • PCV67 - STAR ANALYSIS AND FORECAST MODELLING TO ESTIMATE VALUE FOR MONEY OF ORAL ANTICOAGULANTS

    Oct 1, 2018, 00:00

  • PMH3 - COMPARING THE RISK OF SUICIDALITY IN ADULT VERSUS YOUTH PATIENTS TREATED WITH SEROTONIN REUPTAKE INHIBITORS - A REAL-WORLD EVIDENCE-BASED APPROACH

    Oct 1, 2018, 00:00

  • PMU4 - THE SAFETY OF SWITCHING BETWEEN REFERENCE BIOPHARMACEUTICALS AND BIOSIMILARS- A SYSTEMATIC REVIEW

    Oct 1, 2018, 00:00

  • PCP42 - ECONOMIC EVALUATION OF INTELLIGENT ROLLATORS – ESTIMATING THEIR BENEFITS

    Oct 1, 2018, 00:00

  • PIH31 - USE OF ADMINISTRATIVE DATA FOR ASSESSMENT OF MEDICATION PRESCRIPTION PRACTICE IN TWO ITALIAN SETTINGS

    Oct 1, 2018, 00:00

  • PCN42 - EFFICACY OF THIRD LINE TYROSINE KINASE INHIBITORS FOR TREATMENT OF ADVANCED GASTROINTESTINAL STROMAL TUMOURS- SYSTEMATIC REVIEW AND META-ANALYSIS

    Oct 1, 2018, 00:00

  • PCN78 - EVALUATING THE ECONOMIC CONSEQUENCES OF NOVEL AGENTS FOR TREATING HODGKIN LYMPHOMA IN GREECE

    Oct 1, 2018, 00:00

  • PCN353 - CONSTRUCT VALIDITY OF EQ-5D-3L IN NON-MELANOMA SKIN CANCER (NMSC)

    Oct 1, 2018, 00:00

  • PMD159 - ASSESSMENT OF THE MARKET ACCESS POTENTIAL OF A NOVEL MEDICAL DEVICE AND APP COMBINATION FOR AN ORPHAN DISEASE

    Oct 1, 2018, 00:00

  • PMU52 - COST IN COMPLEX ABDOMINAL OPERATIONS IN PUBLIC HEALTH INSURANCE PERSPECTIVE FOR TURKEY

    Oct 1, 2018, 00:00

  • PCV52 - COST COMPARISON- STRATEGIES OF PATIENTS MANAGEMENT IN ORAL ANTICOAGULANT THERAPY

    Oct 1, 2018, 00:00

  • PRS12 - DEVELOPMENT AND VALIDATION OF AN ALGORITHM IDENTIFYING CHRONIC THROMBOEMBOLIC PULMONARY HYPERTENSION (CTEPH) IN HOSPITAL DISCHARGE DATABASES

    Oct 1, 2018, 00:00

  • PIH6 - DEVELOPMENT AND VALIDATION OF A SCREENING QUESTIONNAIRE TO DETECT HEAVY MENSTRUAL BLEEDING IN GYNAECOLOGY- THE SAMANTA QUESTIONNAIRE

    Oct 1, 2018, 00:00

  • PHP37 - SPEEDING TO MARKET? AN EVALUATION OF ACCELERATED DRUG APPROVAL PATHWAYS IN AUSTRALIA, CANADA, AND SAUDI ARABIA

    Oct 1, 2018, 00:00

  • PCN340 - REAL-WORLD USAGE OF BORTEZOMIB IN COMBINATION WITH MELPHALAN AND PREDNISONE (VMP) AS FRONTLINE (FL) TREATMENT IN STEM CELL TRANSPLANT (SCT) INELIGIBLE MULTIPLE MYELOMA (MM) PATIENTS ACROSS EU5 COUNTRIES

    Oct 1, 2018, 00:00

  • PCN379 - QUANTITATIVE COMPARISON OF THE INFLUENCE OF OPEN LABEL TRIAL DESIGN ON PATIENT REPORTED OUTCOME RESPONSES – A METASTATIC MELANOMA CASE STUDY.

    Oct 1, 2018, 00:00

  • PHP296 - MANAGED ACCESS AGREEMENTS (MAAS) AND CONTINUING DATA COLLECTION AFTER PROVISIONAL POSITIVE RECOMMENDATION FROM THE NATIONAL INSTITUTE FOR HEALTH AND CARE EXCELLENCE (NICE)

    Oct 1, 2018, 00:00

  • PHP182 - EXTERNAL REFERENCE PRICING- CONSEQUENCES OF FRENCH PRICE DECREASES ON INTERNATIONAL TURNOVER

    Oct 1, 2018, 00:00

  • PSY192 - PATIENT HEALTH-RELATED QUALITY OF LIFE ASSOCIATED WITH REMISSION OF ATTP, A REGRESSION ANALYSIS USING NON-RANDOMISED OBSERVATIONAL DATA FROM THE OKLAHOMA TTP REGISTRY

    Oct 1, 2018, 00:00

  • PND2 - RISK OF PARKINSON’S DISEASE (PD) IN PATIENTS TAKING ADRENERGIC DRUG TREATMENTS

    Oct 1, 2018, 00:00

  • PHP350 - PERFORMANCE AND OUTCOMES BASED CONTRACTS IN THE EU AND USA- COMPARISON OF TRENDS AND RECENT DEVELOPMENTS

    Oct 1, 2018, 00:00

  • PCP5 - THE ECOLOGICAL AND SOCIAL COSTS AND BENEFITS OF INTERVENTIONS – USING THE PRODUCT CARBON FOOTPRINT IN VALUE ASSESSMENT

    Oct 1, 2018, 00:00

  • PHP325 - ORPHAN DRUGS‘ MARKET ACCESS CHALLENGES IN EUROPE FROM A GERMAN PERSPECTIVE

    Oct 1, 2018, 00:00

  • PHP358 - TIME-LIMITED G-BA RESOLUTIONS – A TOOL TO APPROPRIATELY MANAGE REIMBURSEMENT OF INNOVATIVE THERAPIES RECEIVING EXPEDITED REGULATORY APPROVAL

    Oct 1, 2018, 00:00

  • PND15 - TREATMENT AND CHARACTERISTICS OF PEDIATRIC PATIENTS WITH FOCAL EPILEPSY IN GERMANY

    Oct 1, 2018, 00:00

  • PCN101 - COSTS AND HEALTHCARE RESOURCE USE ASSOCIATED WITH MAINTENANCE THERAPY IN MULTIPLE MYELOMA- A SYSTEMATIC LITERATURE REVIEW

    Oct 1, 2018, 00:00

  • PCV36 - ESTIMATION OF THE INCREASED RISK ASSOCIATED WITH RECURRENT EVENTS OR POLY-VASCULAR ATHEROSCLEROTIC CARDIOVASCULAR DISEASE IN THE UNITED KINGDOM FOR USE IN ECONOMIC EVALUATIONS

    Oct 1, 2018, 00:00

  • PCN129 - TREATMENT COSTS AND PROGRESSION-FREE SURVIVAL OF DVD AND KRD REGIMENS SEQUENCES IN THE BRAZILIAN PRIVATE HEALTHCARE SYSTEM

    Oct 1, 2018, 00:00

  • PMU114 - COMPARING A DIRECT AND STAGED APPROACH TO ITEM SELECTION IN A MULTI-DIMENSIONAL PATIENT-REPORTED OUTCOME MEASURE

    Oct 1, 2018, 00:00

  • PRM78 - TECHNIQUES FOR PREVENTION AND DETECTION OF FRAUD IN RANDOMISED CONTROLLED TRIALS BASED ON ROUTINELY COLLECTED ELECTRONIC HEALTH RECORDS

    Oct 1, 2018, 00:00

  • PCP29 - BRAZILIAN PHARMACEUTICAL CLINICAL SERVICES- A DOCUMENTARY ANALYSIS

    Oct 1, 2018, 00:00

  • PIN85 - TENOFOVIR ALAFENAMIDE’S IMPACT ON COMORBIDITIES AMONG PEOPLE LIVING WITH HIV IN PORTUGAL- A SIMULATION STUDY

    Oct 1, 2018, 00:00

  • PSY19 - USING A BAYESIAN NETWORK META-ANALYSIS (NMA) TO COMPARE FERRIC MALTOL TO TREATMENTS FOR IRON DEFICIENCY AND IRON DEFICIENCY ANAEMIA EXCLUDING CHF AND CKD PATIENTS

    Oct 1, 2018, 00:00

  • PSS1 - SYSTEMATIC REVIEWS OF OPHTHALMIC ADVERSE DRUG REACTIONS PUBLISHED IN OPHTHALMOLOGY JOURNALS- A METHODOLOGICAL ASSESSMENT

    Oct 1, 2018, 00:00

  • PIN104 - MENINGOCOCCAL GROUP B (MENB) VACCINE SERIES COMPLETION AND COMPLIANCE AMONG COMMERCIALLY-INSURED INDIVIDUALS AGED 16-23 IN THE UNITED STATES

    Oct 1, 2018, 00:00

  • PCP11 - ORGANISATIONAL MODELS AND OPPORTUNITIES FOR EFFICIENCY MEASURING IN HEALTH CARE

    Oct 1, 2018, 00:00

  • PSY223 - QUALITATIVE RESEARCH IN HAEMOPHILIA A- EMICIZUMAB TRANSFORMS LIFESTYLE OF PATIENTS WITH INHIBITOR

    Oct 1, 2018, 00:00

  • PDB38 - BUDGET IMPACT ANALYSIS OF BENAGLUTIDE INJECTION IN THE TREATMENT OF TYPE 2 DIABETES IN CHINA

    Oct 1, 2018, 00:00

  • PMH6 - LURASIDONE INDUCED SUICIDAL IDEATION AND HALLUCINATION- DISPROPORTIONALITY ANALYSIS IN FDA ADVERSE EVENT REPORTING SYSTEM DATABASE

    Oct 1, 2018, 00:00

  • PIN38 - CLINICAL AND ECONOMIC IMPACT OF THE TREATMENT OF CHRONIC HEPATITIS C IN PRISON INMATES IN SPAIN

    Oct 1, 2018, 00:00

  • PRM155 - JOINT MODELING OF OVERALL SURVIVAL AND PROGRESSION FREE SURVIVAL

    Oct 1, 2018, 00:00

  • PIN42 - DETERMINATING THE ACCEPTABLE PRICE FOR QUADRIVALENT INFLUENZA VACCINE IN RUSSIA

    Oct 1, 2018, 00:00

  • PND60 - COST-EFFECTIVENESS OF TERIFLUNOMIDE FOR THE TREATMENT OF RELAPSING-REMITTING MULTIPLE SCLEROSIS IN GREECE

    Oct 1, 2018, 00:00

  • PND117 - PHYSICIAN REPORTED ADHERENCE IN MS PATIENTS TREATED WITH INJECTABLE PLATFORM THERAPIES VERSUS DELAYED-RELEASE DIMETHYL FUMARATE- FINDINGS FROM A REAL-WORLD CROSS-SECTIONAL STUDY

    Oct 1, 2018, 00:00

  • PHP161 - ASSESSING THE NET PRICE LEVEL OF GENERICS IN GREECE- THE EFFECT OF COMPULSORY PAYBACKS

    Oct 1, 2018, 00:00

  • PND85 - PROPHYLACTIC MIGRAINE MEDICATION USE IN PRIMARY CARE SETTING IN FINLAND

    Oct 1, 2018, 00:00

  • PMH1 - PATIENT-REPORTED SIDE EFFECTS OF BUPRENORPHINE-NALOXONE- IDENTIFYING INDEPENDENT PREDICTORS FROM PATIENT VIEWS AND CLINICAL ASSESSMENT DURING MAINTENANCE TREATMENT OF HEROIN USE DISORDER

    Oct 1, 2018, 00:00

  • PCP61 - EVIDENCE-BASED VALUE OF PD-1 / PD-L1 INHIBITORS IN NSCLC- COMPARISON OF VALUE TO PRICE

    Oct 1, 2018, 00:00

  • Assessing Rationality in Discrete Choice Experiments in Health- An Investigation into the Use of Dominance Tests

    Oct 1, 2018, 00:00

  • PDB123 - WHAT ARE THE MOST VALUED PATIENT OUTCOMES REGARDING MEDICAL CARE FOR FRENCH PATIENTS WITH TYPE 1 DIABETES? RESULTS FROM AN ONLINE PATIENT COMMUNITY (CARENITY.COM)

    Oct 1, 2018, 00:00

  • PND29 - LONG RANGE SIMULATION OF THE COST BURDEN OF DIFFERENCE TREATMENT SEQUENCES APPROVED FOR THE TREATMENT OF HIGHLY ACTIVE RELAPSING MULTIPLE SCLEROSIS IN PORTUGAL

    Oct 1, 2018, 00:00

  • PMD30 - BUDGET IMPACT ANALYSIS OF ROUTINE ADOPTION OF NON-INVASIVE PRENATAL TESTING (NIPT) IN DIFFERENT RISK-SCORE PREGNANCY POPULATIONS IN THE UK

    Oct 1, 2018, 00:00

  • PCN176 - A COST-EFFECTIVENESS ANALYSIS OF ATEZOLIZUMAB VERSUS DOCETAXEL FOR PREVIOUSLY TREATED LOCALLY ADVANCED OR METASTATIC NON-SMALL CELL LUNG CANCER IN BELGIUM

    Oct 1, 2018, 00:00

  • PMD19 - EFFECTIVENESS OF REAL-TIME POLYMERASE CHAIN REACTION FOR THE DIAGNOSIS AND MONITORING OF ADENOVIRUS- A SYSTEMATIC REVIEW

    Oct 1, 2018, 00:00

  • PSY32 - CLAIMS-BASED ANALYSIS OF HOMOCYSTEINE TESTING, ELEVATED HOMOCYSTEINE LEVELS, AND HOMOCYSTINURIA DIAGNOSIS IN THE U.S.

    Oct 1, 2018, 00:00

  • PMD155 - IMPACT OF MINIMALLY INVASIVE TREATMENTS FOR PERIPHERAL ARTERIAL DISEASE IN HUNGARY

    Oct 1, 2018, 00:00

  • PRM35 - INCREMENTAL COST EFFECTIVENESS RATIO (ICER) THRESHOLD, THE END OF HORIZONTAL EQUITY?

    Oct 1, 2018, 00:00

  • PCN358 - SATISFACTION WITH HEALTH CARE ANALYSIS IN CERVIX-UTERI CANCER MEXICAN WOMEN TREATED IN A THIRD LEVEL PUBLIC FACILITY

    Oct 1, 2018, 00:00

  • PCN111 - COST ESTIMATE OF IMMUNE-RELATED ADVERSE REACTIONS ASSOCIATED WITH INNOVATIVE TREATMENTS OF METASTATIC MELANOMA

    Oct 1, 2018, 00:00

  • PCV38 - BUDGET IMPACT OF ALIROCUMAB IN THE MANAGEMENT OF HETEROZYGOUS FAMILIAL HYPERCHOLESTEROLEMIA PATIENTS IN ARGENTINA

    Oct 1, 2018, 00:00

  • PMU75 - IS ADOPTING A LOW PRICE STRATEGY TO GAIN MARKET ACCESS COMPATIBLE WITH A VIABLE GENE/CELL THERAPY BUSINESS?

    Oct 1, 2018, 00:00

  • PMD53 - REMOVABLE DINOPROSTONE VAGINAL DELIVERY SYSTEM- COST-CONSEQUENCES MODEL FOR CENTRAL AND EASTERN EUROPE COUNTRIES

    Oct 1, 2018, 00:00

  • PUK2 - PREDICTORS FOR BLOOD PRESSURE CONTROL AMONG POST DIALYSIS HYPERTENSIVE PATIENTS WHEN TREATED WITH AND WITHOUT RAAS INHIBITOR

    Oct 1, 2018, 00:00

  • RM2 - MIXTURE METHODS INCORPORATING GENERAL POPULATION MORTALITY IN THE LIKELIHOOD FUNCTION OF PARAMETRIC DISTRIBUTIONS

    Oct 1, 2018, 00:00

  • PSY90 - RETROSPECTIVE ANALYSIS OF ADMINISTRATIVE DATA TO ASSESS ADHERENCE, PHARMACOUTILIZATION AND COSTS OF BIOLOGICAL THERAPY TREATMENT OF PSORIASIS IN SOUTHERN ITALIAN SETTING

    Oct 1, 2018, 00:00

  • PIN40 - COST-EFFECTIVENESS OF FIRST-LINE TREATMENT FOR INVASIVE ASPERGILOSIS IN COLOMBIA

    Oct 1, 2018, 00:00

  • PCN241 - OLAPARIB USE AND TREATMENT OUTCOMES IN SWEDISH PATIENTS TREATED DURING THE FIRST THREE YEARS FOLLOWING REGULATORY APPROVAL

    Oct 1, 2018, 00:00

  • PMD168 - MARKET ACCESS FOR COMPANION DIAGNOSTICS IN ONCOLOGY IN THE EU5 AND ASIA-PACIFIC REGION

    Oct 1, 2018, 00:00

  • PMS81 - CONSENSUS ON THE MEASUREMENT INSTRUMENTS TO EVALUATE THE EFFECTIVENESS OF BIOLOGICAL TREATMENT IN PSORIATIC ARTHRITIS- MERECES STUDY.

    Oct 1, 2018, 00:00

  • PMD69 - SYSTEMATIC REVIEW AND ECONOMIC ANALYSIS OF ANTISEPTIC BARRIER CAPS IN PATIENTS WITH CENTRAL OR PERIPHERAL LINE CATHETERS

    Oct 1, 2018, 00:00

  • PHP269 - DESIGN AND EVALUATION OF MALAYSIAN MODEL OF PHARMACEUTICAL PICTOGRAMS

    Oct 1, 2018, 00:00

  • PCN8 - SEVERITY OF BREAST CANCER ASSOCIATED WITH TYPE 2 DIABETES AND NOT WITH INSULIN TREATMENT

    Oct 1, 2018, 00:00

  • PIN14 - BIOMEDICAL AND THERAPEUTIC PREDICTORS OF SURVIVAL TIME AND MORTALITY OF ADULT HIV/TB CO-INFECTIONS; A RETROSPECTIVE COHORT STUDY

    Oct 1, 2018, 00:00

  • PHP133 - TOWARDS IMPLEMENTING MEDICATION THERAPY MANAGEMENT SERVICE IN MALAYSIA- PERCEPTIONS AND CHALLENGES

    Oct 1, 2018, 00:00

  • PMS30 - COST ANALYSIS FOR DIFFERENT ANTI-RHEUMATOID BIOLOGICAL TREATMENTS AFTER FAILURE OF CONVENTIONAL DMARDS IN PATIENTS WITH MODERATE TO SEVERE RHEUMATOID ARTHRITIS IN THE KINGDOM OF SAUDI ARABIA

    Oct 1, 2018, 00:00

  • PCN253 - DID THE EUROPEAN FINANCIAL CRISIS HAVE AN IMPACT ON ECONOMIC DECISION-MAKING IN HEALTH TECHNOLOGY ASSESSMENTS?

    Oct 1, 2018, 00:00

  • PMS4 - RHEUMATOID ARTHRITIS TREATED WITH SIX-MONTHS OF FIRST-LINE BIOLOGIC OR BIOSIMILAR THERAPY- A SYSTEMATIC REVIEW AND NETWORK META-ANALYSIS

    Oct 1, 2018, 00:00

  • PMU59 - ARE THERE ANY IMPLICIT GUIDELINES FOR INCLUDING ADVERSE EVENTS IN COST-EFFECTIVENESS MODELS INTENDED FOR FRENCH HEALTH AUTHORITIES? AN ANALYSIS OF EFFICIENCY OPINIONS

    Oct 1, 2018, 00:00

  • PHP156 - A SCENARIO ANALYSIS OF THE IMPACT OF TREATMENT SETTING ON HEALTH CARE COST AND TREATMENT OUTCOMES

    Oct 1, 2018, 00:00

  • PDB60 - COST-CONSEQUENCE ANALYSIS FOR RECOMBINANT HUMAN GROWTH HORMONE TREATMENT ADMINISTERED VIA DIFFERENT DEVICES IN CHILDREN WITH GROWTH HORMONE DEFICIENCY IN ITALY

    Oct 1, 2018, 00:00

  • PHP369 - CHALLENGES IN ACHIEVING MARKET ACCESS SUCCESS FOR ADVANCED THERAPIES IN EUROPE- A CASE STUDY

    Oct 1, 2018, 00:00

  • PCV74 - COST-EFFECTIVENESS ANALYSIS OF ROSUVASTATIN COMPARED TO ATORVASTATIN IN SPANISH PATIENTS AT MODERATE, HIGH, AND VERY HIGH CARDIOVASCULAR RISK

    Oct 1, 2018, 00:00

  • PMS53 - VALIDATION IN A REAL WORLD SCENARIO OF A CLINICAL DECISION SUPPORT SYSTEM FOR THE PREVALENCE, FRACTURE RISKS AND TREATMENT OF OSTEOPOROSIS IN THE BRAZILIAN PRIVATE MARKET

    Oct 1, 2018, 00:00

  • PSY139 - CURRENT USE OF FACTOR VIII PRODUCTS IN CHILDREN AND ADOLESCENTS WITH MODERATE OR SEVERE HAEMOPHILIA A

    Oct 1, 2018, 00:00

  • PMH15 - A NETWORK META-ANALYSIS OF MEDICINES USED FOR ATTENTION DEFICIT HYPERACTIVITY DISORDER IN ADULTS

    Oct 1, 2018, 00:00

  • PSY191 - HEALTH STATE UTILITIES ASSOCIATED WITH TREATMENT FOR TRANSFUSION DEPENDENT B-THALASSEMIA

    Oct 1, 2018, 00:00

  • PMU13 - REALIZING TRANSPARENCY- REGISTRATION OF REAL-WORLD EVIDENCE STUDIES OF TREATMENT AND/OR COMPARATIVE EFFECTIVENESS

    Oct 1, 2018, 00:00

  • PCV43 - BUDGET IMPACT ANALYSIS OF THE INTRODUCTION OF A SINGLE-PILL COMBINATION OF ATORVASTATIN, PERINDOPRIL AND AMLODIPINE IN THE GREEK SETTING

    Oct 1, 2018, 00:00

  • PCN184 - COST-EFFECTIVENESS OF NIVOLUMAB PLUS IPILIMUMAB IN ADVANCED MELANOMA

    Oct 1, 2018, 00:00

  • PMD50 - MAGNETIC RESONANCE-GUIDED FOCUSSED ULTRASOUND VERSUS DEEP BRAIN STIMULATION IN MEDICALLY-REFRACTORY ESSENTIAL TREMOR- A COST-CONSEQUENCE ANALYSIS IN THE UK SETTING

    Oct 1, 2018, 00:00

  • PDB37 - BUDGET IMPACT ANALYSIS OF THE ADULT TYPE 1 DIABETES MELLITUS NATIONAL CLINICAL GUIDELINE IN IRELAND

    Oct 1, 2018, 00:00

  • PCN21 - COMPARATIVE EFFICACY OF NIVOLUMAB±IPILIMUMAB VERSUS STANDARD OF CARE (SOC) FOR THIRD-LINE (3L) PATIENTS WITH RECURRENT SMALL CELL LUNG CANCER (SCLC) USING POPULATION-ADJUSTED INDIRECT COMPARISON

    Oct 1, 2018, 00:00

  • PCN2 - EFFECTIVENESS AND SAFETY OF PEMBROLIZUMAB IN ADVANCED OR METASTATIC MELANOMA- PRELIMINARY RESULTS FROM REAL WORLD

    Oct 1, 2018, 00:00

  • PIH38 - PREVALENCE OF PELVIC FLOOR DISORDERS AMONG WOMEN IN EASTERN REGION OF NEPAL

    Oct 1, 2018, 00:00

  • PSY165 - PRICE DIFFERENCES FOR ORPHAN DRUGS ACROSS THE EU-5 COUNTRIES- A COMPARATIVE ASSESSMENT

    Oct 1, 2018, 00:00

  • PHP360 - THE EFFECT OF EUNETHTA ASSESSMENTS ON NATIONAL HTA DECISION MAKING

    Oct 1, 2018, 00:00

  • PSY164 - DRIVERS OF ORPHAN MEDICINAL PRODUCT VALUE, PRICE AND COSTS – A PRACTICAL EXPLORATORY ANALYSIS

    Oct 1, 2018, 00:00

  • PRM160 - IMPACT OF POST-PROGRESSION OLARATUMAB (OLARA) MONOTHERAPY FOLLOWING DOXORUBICIN (DOX) MONOTHERAPY ON OVERALL SURVIVAL (OS).

    Oct 1, 2018, 00:00

  • PCN373 - UNDERSTANDING PATIENT PERSPECTIVES OF RENAL CELL CARCINOMA USING SOCIAL MEDIA- A QUALITATIVE ANALYSIS

    Oct 1, 2018, 00:00

  • PCP39 - INNOVATION IN IDENTIFYING BARRIERS TO ACCESS AND IMPROVING THE QUALITY OF CANCER CARE AND TREATMENT FOR VULNERABLE AREAS PEOPLE, ARGENTINA 2017

    Oct 1, 2018, 00:00

  • PMS102 - THE RELATION BETWEEN TRAINING METHODS AND FORMED INJURIES AMONG PEOPLE DOING WEIGHT TRAINING

    Oct 1, 2018, 00:00

  • PDB121 - QUALITY OF LIFE AND UTILITY VALUES FOR COST-EFFECTIVENESS MODELING IN JAPANESE PATIENTS WITH TYPE 2 DIABETES

    Oct 1, 2018, 00:00

  • PCV142 - ADHERENCE TO ORAL ANTICOAGULATION TREATMENT IN ATRIAL FIBRILLATION AND THE IMPACT OF PATIENT SATISFACTION

    Oct 1, 2018, 00:00

  • PCN169 - A FLEXIBLE OPEN-SOURCE COST-EFFECTIVENESS MODEL FOR METASTATIC EGFR+ NON-SMALL CELL LUNG CANCER

    Oct 1, 2018, 00:00

  • PCV86 - COST-EFFECTIVENESS OF SACUBITRIL/VALSARTAN IN THE TREATMENT OF HEART FAILURE UNDER THE BRAZILIAN PRIVATE HEALTHCARE SYSTEM PERSPECTIVE

    Oct 1, 2018, 00:00

  • AC1 - OUTCOME OF NEW DRUG NEGOTIATION PROCESS IN ITALY- APPROVAL CONDITIONS (2015-2018)

    Oct 1, 2018, 00:00

  • PCN336 - TREATMENT OF METASTATIC CASTRATION-RESISTANT PROSTATE CANCER PATIENTS PREVIOUSLY TREATED WITH DOCETAXEL IN PORTUGAL

    Oct 1, 2018, 00:00

  • PCN282 - CANCER DRUGS FUND (CDF) IN THE UNITED KINGDOM- A 2-YEAR ANALYSIS

    Oct 1, 2018, 00:00

  • PRS80 - HEALTH TECHNOLOGY ASSESSMENT DECISIONS FOR NOVEL ASTHMA THERAPIES- RESULTS, RATIONALE, AND TRENDS

    Oct 1, 2018, 00:00

  • PHP165 - THE LONG-TERM CHANGE OF MEDICAL SERVICE PRICE- AN INTERNATIONAL COMPARISON OF SELECTED COUNTRIES

    Oct 1, 2018, 00:00

  • PRS99 - IMPACT OF COUGH AND MUCUS ON THE EMOTIONAL AND PSYCHOSOCIAL WELLBEING IN PATIENTS WITH CHRONIC OBSTRUCTIVE PULMONARY DISEASE- A QUALITATIVE PATIENT ONLINE BULLETIN BOARD STUDY

    Oct 1, 2018, 00:00

  • PHP352 - SUCCESS FACTORS FOR THE IMPLEMENTATION OF MARKET ACCESS AGREEMENTS IN EMERGING MIDDLE-INCOME MARKETS IN PREPARATION FOR OUTCOMES BASED CONCEPTS

    Oct 1, 2018, 00:00

  • PMU61 - BEYOND THE COST-EFFECTIVENESS ACCEPTABILITY CURVE- THE APPROPRIATENESS OF RANK PROBABILITIES FOR PRESENTING THE RESULTS OF ECONOMIC EVALUATION IN MULTIPLE TECHNOLOGY APPRAISAL

    Oct 1, 2018, 00:00

  • PMU106 - CHOOSING VIDEO INSTEAD OF IN-CLINIC CONSULTATIONS IN PRIMARY CARE- DISCRETE CHOICE EXPERIMENT AMONG KEY STAKEHOLDERS- PATIENTS, PRIMARY CARE PRACTITIONERS AND POLICY MAKERS

    Oct 1, 2018, 00:00

  • PHP265 - LANDSCAPE ASSESSMENT OF A MENA HEALTHCARE DATABASE FOR USE IN HEALTH ECONOMICS MODELING

    Oct 1, 2018, 00:00

  • PMD135 - DETERMINING FACTORS FOR DECISION-MAKING IN THE MEDICAL TECHNOLOGIES EVALUATION PROGRAMME

    Oct 1, 2018, 00:00

  • PCN333 - REAL-WORLD TREATMENT PATTERNS OF PATIENTS WITH ADVANCED (STAGE II-IV) OVARIAN CANCER CLASSIFIED AS RESISTANT OR REFRACTORY TO FRONTLINE PLATINUM-BASED THERAPY

    Oct 1, 2018, 00:00

  • PRM276 - METHODOLOGICAL ISSUES OF DRUG PRICE COMPARISON STUDIES- WHAT IMPROVEMENT IN QUALITY?

    Oct 1, 2018, 00:00

  • PGI31 - PATTERNS OF ANTI-TNF ADOPTION AND DIFFUSION- REAL WORLD EVIDENCE FROM A 12-YEAR COHORT OF CROHN'S DISEASE AND ULCERATIVE COLITIS PATIENTS TREATED IN TERTIARY REFERAL MEDICAL CENTERS IN ISRAEL

    Oct 1, 2018, 00:00

  • PHP58 - SPANISH THERAPEUTIC POSITIONING REPORTS- 6-YEAR UPDATE – INCREASING IN FREQUENCY BUT NOT RELEVANCE?

    Oct 1, 2018, 00:00

  • PIH11 - ANTIEMETIC USE IN PREGNANCY AND THE RISK OF MAJOR CONGENITAL MALFORMATIONS- A POPULATION-BASED COHORT STUDY

    Oct 1, 2018, 00:00

  • PDB95 - REAL WORLD EVIDENCE ON TYPE 2 DIABETES- IDENTIFICATION AND CHARACTERIZATION OF NON-INSULIN TREATED PATIENTS WHO FULFIL CONDITIONS FOR THAT TREATMENT

    Oct 1, 2018, 00:00

  • PIN9 - NOVEL APPROACH FOR INFLUENZA VACCINATION- APPLICATION OF AN EMERGING TECHNOLOGIES EVALUATION STRATEGY

    Oct 1, 2018, 00:00

  • PSY50 - BUDGET-IMPACT ANALYSIS (BIA) OF CHRONIC PAIN SYNDROMES FROM A HEALTHCARE PAYER PERSPECTIVE IN BRAZIL

    Oct 1, 2018, 00:00

  • PND34 - PAYER AND SOCIETAL BENEFIT OF PEGINTERFERON BETA-1A VERSUS GLATIRAMER ACETATE IN PATIENTS WITH RELAPSING-REMITTING MULTIPLE SCLEROSIS IN SPAIN

    Oct 1, 2018, 00:00

  • PCV114 - PATIENT AND PHYSICIAN CHARACTERISTICS ASSOCIATED WITH PRESCRIPTION OF NOVEL ORAL COAGULANTS IN A LARGE HEALTHCARE SERVICE PROVIDER IN ISRAEL

    Oct 1, 2018, 00:00

  • PCN279 - A REVIEW OF RECOMMENDATIONS FOR INCLUSION AND DATA COLLECTION WITHIN THE CDF FRAMEWORK

    Oct 1, 2018, 00:00

  • RM3 - IS PATIENT CHOICE PREDICTABLE? THE IMPACT OF DISCRETE CHOICE EXPERIMENT DESIGNS AND MODELS

    Oct 1, 2018, 00:00

  • PSY56 - COST-UTILITY OF NEW FILM-COATED TABLET FORMULATION OF DEFERASIROX VERSUS DEFEROXAMINE AMONG MAJOR B-THALASSEMIA PATIENTS IN IRAN

    Oct 1, 2018, 00:00

  • PCP2 - IS DIGITAL TECHNOLOGY BRINGING THE ADOPTERS CLOSER TO THE DECISION-MAKERS- A COMPARATIVE ASSESSMENT ACROSS FIVE EUROPEAN MARKETS.

    Oct 1, 2018, 00:00

  • PMD103 - COST-EFFECTIVENESS AND COST-UTILITY ANALYSIS OF TREATING LEG ULCERS WITH URGOSTART COMPARED TO A NEUTRAL DRESSING.

    Oct 1, 2018, 00:00

  • PCN65 - LONG- TERM SURVIVAL AMONG PATIENTS WITH HIGH-GRADE GLIOMA TREATED WITH NIMOTUZUMAB

    Oct 1, 2018, 00:00

  • PRM214 - DO UTILITY VALUES USED IN HEALTH TECHNOLOGY ASSESSMENT MAINLY COME FROM WIDELY CITED REFERENCES?

    Oct 1, 2018, 00:00

  • PMS118 - QUALITY OF LIFE OF DUPUYTREN’S DISEASE PATIENTS TREATED WITH COLLAGENASE CLOSTRIDIUM HISTOLYTICUM- A PROSPECTIVE COHORT STUDY

    Oct 1, 2018, 00:00

  • PHP291 - SHAPING THE FUTURE OF EUROPEAN HEALTH TECHNOLOGY ASSESSMENTS- EXPERIENCES OF THREE PHARMACEUTICAL JOINT RAPID RELATIVE EFFECTIVENESS ASSESSMENTS

    Oct 1, 2018, 00:00

  • PSY202 - THE OCCUPATIONAL HAZARDS OF MEASURING RISK TOLERANCE- CONVERGENT VALIDITY IN PREFERENCE ELICITATION.

    Oct 1, 2018, 00:00

  • PSY205 - BODY IMAGE IN SLE AND THE RELATIONSHIP BETWEEN DISEASE ACTIVITY AND PSYCHOSOCIAL CONCERNS

    Oct 1, 2018, 00:00

  • PCN195 - COST-UTILITY ANALYSIS OF THE GERMLINE BRCA TESTING IN WOMEN WITH EPITHELIAL OVARIAN CANCER WITHOUT FAMILY HISTORY IN SPAIN

    Oct 1, 2018, 00:00

  • PCV116 - DISCONTINUATION AND HEALTH CARE RESOURCE UTILISATION IN NON-VALVULAR ATRIAL FIBRILLATION PATIENTS TREATED WITH APIXABAN OR WARFARIN IN ENGLAND

    Oct 1, 2018, 00:00

  • PMD66 - COMPARING THE LONG-TERM IMPACT ON HEALTHCARE RESOURCES AND COSTS DUE TO SINGLE-PIECE ACRYLIC INTRAOCULAR LENS (IOLS) IMPLANTATION DURING CATARACT SURGERY- A COST-CONSEQUENCE ANALYSIS FROM UK HEALTHCARE SYSTEM PERSPECTIVE

    Oct 1, 2018, 00:00

  • PRM177 - CAN THE EQ-5D HELP UNDERSTAND HOW CHANGES IN CLINICAL OUTCOMES IMPACT ON DIFFERENT CONCEPTS OF HEALTH?

    Oct 1, 2018, 00:00

  • PRM64 - THE NEED FOR INNOVATIVE SURVIVAL MODELLING APPROACHES IN HEALTH TECHNOLOGY ASSESSMENTS (HTA) OF EARLY-STAGE ONCOLOGY INDICATIONS

    Oct 1, 2018, 00:00

  • PMD22 - THE EFFECTIVENESS OF ELECTRONIC LARYNX FOR SPEECH REHABILITATION OF LARINGECTOMIZED PATIENTS- A REVIEW OF THE LITERATURE

    Oct 1, 2018, 00:00

  • PSS72 - FAMILY PSO- IMPACT OF PSORIASIS ON THE PARTNER

    Oct 1, 2018, 00:00

  • PCN77 - BUDGET IMPACT ANALYSIS OF BLINATUMOMAB FOR THE TREATMENT OF PEDIATRIC PATIENTS WITH PHILADELPHIA NEGATIVE RELAPSED OR REFRACTORY B-CELL PRECURSOR ACUTE LYMPHOBLASTIC LEUKEMIA IN MEXICO

    Oct 1, 2018, 00:00

  • PND76 - THE ECONOMIC CONSEQUENCES OF BENEFITS OF DELAYED-RELEASE DIMETHYL FUMARATE TREATMENT VERSUS BETA INTERFERONS AND GLATIRAMER ACETATE ON ABILITY TO WORK OF MULTIPLE SCLEROSIS PATIENTS IN ITALY

    Oct 1, 2018, 00:00

  • PMU82 - SOCIOECONOMIC AND HEALTH-RELATED FACTORS ASSOCIATED WITH ADHERENCE TO CHRONIC MEDICATION IN GREECE

    Oct 1, 2018, 00:00

  • PSY214 - PHYSICAL ACTIVITY AND QUALITY OF LIFE OUTCOMES IN MULTIPLE MYELOMA PATIENTS- A SYSTEMATIC REVIEW

    Oct 1, 2018, 00:00

  • PHP18 - COULD THE ONE-DAY SURGERY PLAY A SIGNIFICANT ROLE IN CATARACT WAITING LIST REDUCTION PROCESS IN HUNGARY?

    Oct 1, 2018, 00:00

  • PMD42 - ECONOMIC IMPACT OF LAPAROSCOPIC VS OPEN SURGERY FOR COLORECTAL CANCER- A BUDGET IMPACT ANALYSIS IN ITALY

    Oct 1, 2018, 00:00

  • Accuracy of Linking VR-12 and PROMIS Global Health Scores in Clinical Practice

    Oct 1, 2018, 00:00

  • CV2 - IMPACT OF ATRIAL FIBRILLATION (AF) AWARENESS CAMPAIGNS ON RATES OF AF RELATED CONSULTATIONS IN UK PRIMARY CARE- INTERRUPTED TIME SERIES ANALYSES.

    Oct 1, 2018, 00:00

  • PSY166 - MARKET ACCESS TRENDS FOR ADVANCED THERAPY MEDICINAL PRODUCTS (ATMPS) IN EUROPE

    Oct 1, 2018, 00:00

  • PRM136 - A PILOT OF ONLINE SURVEY SOFTWARE FOR EXPERT ELICITATION AT NICE

    Oct 1, 2018, 00:00

  • PMD34 - BUDGET IMPACT ANALYSIS (BIA) OF EMPLOYING A FEMALE EXTERNAL CATHETER (FEC) TO ASSIST WITH URINE OUTPUT MANAGEMENT (UOM) IN THE HOSPITAL SETTING

    Oct 1, 2018, 00:00

  • PRM61 - LIMITATIONS AND EXPECTED CHALLENGES OF CAR-T ECONOMIC EVALUATION

    Oct 1, 2018, 00:00

  • PSS27 - A COST-EFFECTIVENESS ANALYSIS OF TWO VISUAL ACUITY CUTOFFS FOR CATARACT SURGERY IN PATIENTS WITH PSEUDOEXFOLIATION IN UNITED KINGDOM

    Oct 1, 2018, 00:00

  • PDB137 - COMPARISON OF ORAL ANTIDIABETIC DRUGS AS ADD-ON TREATMENTS IN PATIENTS WITH TYPE 2 DIABETES UNCONTROLLED ON METFORMIN- A NETWORK META-ANALYSIS

    Oct 1, 2018, 00:00

  • PRS6 - THE CLINICAL EFFECTIVENESS OF PROPHYLACTIC VERSUS SELECTIVE USE OF SURFACTANT IN PRETERM INFANTS- A SYSTEMATIC REVIEW AND META-ANALYSIS

    Oct 1, 2018, 00:00

  • PMS27 - SECUKINUMAB VERSUS ADALIMUMAB IN THE TREATMENT OF PSORIATIC ARTHRITIS- A COST PER RESPONDER ANALYSIS AMONG 48 WEEKS FROM A TUNISIAN PERSPECTIVE.

    Oct 1, 2018, 00:00

  • PGI8 - SYSTEMATIC LITERATURE REVIEW AND INDIRECT TREATMENT COMPARISON OF LINACLOTIDE VERSUS OTHER ORAL CONSTIPATION TREATMENTS IN PATIENTS WITH CHRONIC CONSTIPATION

    Oct 1, 2018, 00:00

  • PCN139 - COST-EFFECTIVENESS ANALYSIS OF PEMBROLIZUMAB FOR PATIENTS WITH LOCALLY ADVANCED OR METASTATIC UROTHELIAL CANCER WHO ARE INELIGIBLE FOR CISPLATIN-CONTAINING CHEMOTHERAPY IN ENGLAND

    Oct 1, 2018, 00:00

  • PIN130 - QUALITY OF LIFE OF ADULT PATIENTS UNDERWENT POLIOMYELITIS INFECTION DURING CHILDHOOD

    Oct 1, 2018, 00:00

  • PSY99 - COST-EFFECTIVENESS OF TOCILIZUMAB + PREDNISOLONE COMPARED TO STANDARD OF CARE WITH PREDNISOLONE ALONE IN PATIENTS WITH GIANT CELL ARTERITIS (GCA) IN TURKEY

    Oct 1, 2018, 00:00

  • PCV109 - ARE CARDIOVASCULAR MEDICINES IN QATAR AND LEBANON AFFORDABLE? AN ANALYSIS AND COMPARISON OF TWO DEVELOPING MIDDLE-EASTERN COUNTRIES

    Oct 1, 2018, 00:00

  • PHP305 - CONSIDERING CHILDREN ALONGSIDE ADULTS IN NICE TECHNOLOGY APPRAISALS AND HIGHLY SPECIALISED TECHNOLOGIES EVALUATIONS

    Oct 1, 2018, 00:00

  • PMU31 - A REVIEW OF MANAGED ACCESS AGREEMENTS (MAAS) AND PATIENT ACCESS SCHEMES (PASS) IN ENGLAND

    Oct 1, 2018, 00:00

  • PSY181 - 2018 UPDATE OF HEALTH TECHNOLOGY ASSESSMENT DECISIONS FOR NOVEL PSORIASIS AND PSORIATIC ARTHRITIS AGENTS- RESULTS, RATIONALE, AND TRENDS

    Oct 1, 2018, 00:00

  • PHP294 - A REVIEW OF RECENT APPRAISALS FROM THE INSTITUTE FOR CLINICAL AND ECONOMIC REVIEW- HOW IMPORTANT IS THE ICER?

    Oct 1, 2018, 00:00

  • PSY186 - CREATING AND MAINTAINING THE BULGARIAN CYSTIC FIBROSIS REGISTRY – NOT REALLY A MISSION IMPOSSIBLE

    Oct 1, 2018, 00:00

  • PCN198 - AN ECONOMIC SYSTEMATIC LITERATURE REVIEW (SLR) FOR ANAPLASTIC LYMPHOMA KINASE-POSITIVE (ALK+) NON-SMALL-CELL LUNG CANCER (NSCLC)

    Oct 1, 2018, 00:00

  • PUK33 - COMPARISON OF TREATMENT PATTERN IN UROLITHIASIS - A POPULATION STUDY USING KOREAN HEALTH INSURANCE REVIEW AND ASSESSMENT SERVICE DATABASE

    Oct 1, 2018, 00:00

  • PHP308 - CONSIDERATION OF LEGAL ASPECTS IN HTA – CAN A SYSTEMATIC AND PRAGMATIC METHODOLOGICAL APPROACH BE IDENTIFIED IN GERMAN HTA?

    Oct 1, 2018, 00:00

  • PND133 - LIVING WITH MIGRAINE- THE IMPACT ON BRAZILIAN PATIENTS LIVES FROM MY MIGRAINE VOICE SURVEY

    Oct 1, 2018, 00:00

  • PHP181 - HEALTH TECHNOLOGY ASSESSMENT OF ONCOLOGY THERAPIES IN SPAIN AND ITALY- KEY METRICS AND CONSIDERATIONS

    Oct 1, 2018, 00:00

  • PSY156 - QUIDS IN? – A REVIEW OF WHETHER POTENTIAL BLOCKBUSTER SAVINGS FROM BIOSIMILAR ADALIMUMAB SHOULD BE REINVESTED IN OTHER DISEASE AREAS?

    Oct 1, 2018, 00:00

  • PHP155 - THE DEVELOPMENT AND EMPIRICAL APPLICATION OF A MULTIPLE SOCIETAL VALUE CRITERIA APPROACH TO RESOURCE ALLOCATION AMONG DISEASE CATEGORIES

    Oct 1, 2018, 00:00

  • PDB75 - COST-EFFECTIVENESS OF TREATING PATIENTS WITH TYPE 2 DIABETES POORLY CONTROLLED ON BASAL INSULIN WITH FIXED-RATIO COMBINATIONS OF BASAL INSULIN AND GLP-1 RECEPTOR AGONISTS IN DENMARK- IDEGLIRA VERSUS IGLARLIXI

    Oct 1, 2018, 00:00

  • PCN385 - QUALITY OF LIFE OF PATIENTS LIVING WITH METASTATIC COLORECTAL CANCER (MCRC)- EUROPEAN ORGANIZATION FOR RESEARCH AND TREATMENT OF CANCER (EORTC) QUESTIONNAIRE RESULTS FROM A REAL WORLD EUROPEAN SURVEY

    Oct 1, 2018, 00:00

  • PCN321 - COMPARISON OF RECOMMENDATIONS FOR CANCER DRUGS CARRIED OUT BY THREE HTA BODIES (2015-2018)- NICE TECHNOLOGY APPRAISALS, GERMAN FEDERAL JOINT COMMITTEE AND SPANISH THERAPEUTIC POSITIONING REPORT

    Oct 1, 2018, 00:00

  • PRS15 - A 10-YEAR FOLLOW-UP OF A COHORT OF PATIENTS WITH CHRONIC OBSTRUCTIVE PULMONARY DISEASE (COPD) THROUGH A ONE-WAY MARKOV MODEL

    Oct 1, 2018, 00:00

  • PDB24 - BASELINE CHARACTERISTICS OF GERMAN DIABETES MELLITUS TYPE-2 PATIENTS WHO INITIATED INSULIN USAGE- A CLAIMS DATA ANALYSIS

    Oct 1, 2018, 00:00

  • PCN204 - A SYSTEMATIC REVIEW OF BARRIERS AND FACILITATORS TO PARTICIPATION IN SHARED DECISION MAKING IN CANCER CARE- AN INTERNATIONAL PERSPECTIVE

    Oct 1, 2018, 00:00

  • PMU21 - ROLE OF PHARMACISTS FROM RESEARCH TO HEALTHCARE- AN IGNORE PARADIGM IN LOWER INCOME COUNTRY COUNTRY

    Oct 1, 2018, 00:00

  • PMU28 - A CROSS INDICATION BUDGET IMPACT ANALYSIS OF SECUKINUMAB- A GREEK PERSPECTIVE

    Oct 1, 2018, 00:00

  • PMD28 - VAGUS NERVE STIMULATION FOR TREATMENT-RESISTANT DEPRESSION- A BUDGET IMPACT ANALYSIS IN ENGLAND

    Oct 1, 2018, 00:00

  • PRM117 - MULTI-COMPARATOR ICERS IN COST-EFFECTIVENESS ANALYSIS TO ACCOUNT FOR CHANGES IN CLINICAL PRACTICE AFTER THE INTRODUCTION OF A NEW TECHNOLOGY

    Oct 1, 2018, 00:00

  • PMD93 - THE COMPARATIVE PHARMACOECONOMIC ANALYSIS OF USING DIFFERENT TYPES OF MONOFOCAL INTRAOCULAR LENSES FOR CATARACT SURGERY IN RUSSIA

    Oct 1, 2018, 00:00

  • PRM69 - AN INCREASE OVER TIME IN PUBLISHED REAL-WORLD AND HEALTH ECONOMIC EVIDENCE IN CLINICAL JOURNALS ACROSS LYSOSOMAL STORAGE DISORDERS

    Oct 1, 2018, 00:00

  • PCV141 - MEDICATION ADHERENCE AND POTENTIAL DETERMINANTS FOR NON-ADHERENCE IN YOUNG AND MALE PATIENTS AT CVD RISK IN KOREA

    Oct 1, 2018, 00:00

  • PIN127 - HETEROGENEOUS PREFERENCES FOR HIV/AIDS COUNSELING AND TESTING AMONG TWO HIGH RISK POPULATIONS IN NORTHERN TANZANIA - RESULTS FROM A DISCRETE CHOICE EXPERIMENT

    Oct 1, 2018, 00:00

  • PMD176 - MEDICATION ADHERENCE ASCERTAINED BY A DIGITAL OBSERVATIONAL STUDY APPROACH USING A MEDICAL APP- A PILOT STUDY AMONG PATIENTS WITH MULTIPLE SCLEROSIS TREATED WITH INTERFERON BETA-1B

    Oct 1, 2018, 00:00

  • PHP234 - EVALUATING THE IMPACT OF VALUE BASED PRICING (VBP) AND HTA ON PRICE LEVELS IN AN EU CONTEXT

    Oct 1, 2018, 00:00

  • PMS90 - A BONE RESORPTION MARKER TO MONITOR DRUG PROFILE IN PATIENTS WITH OSTEOPOROTIC FRACTURES

    Oct 1, 2018, 00:00

  • PRS94 - THE PARENTAL BURDEN OF CARING FOR A CHILD WITH PEANUT ALLERGY IN THE UK

    Oct 1, 2018, 00:00

  • PMU113 - TIME-DEPENDENT VARIATION OF PRO SCORES IN CHRONIC CONDITIONS- A SCOPING REVIEW

    Oct 1, 2018, 00:00

  • PND135 - FATIGUE IN MULTIPLE SCLEROSIS- ASSESSING THE PSYCHOMETRIC PROPERTIES OF THE MFIS-5 QUESTIONNAIRE

    Oct 1, 2018, 00:00

  • PIN118 - KNOWLEDGE, ATTITUDE AND PRACTICES ABOUT ZIKA VIRUS AMONG PHARMACY STUDENTS IN THE UNITED STATES (US) AND INDIA- A CROSS SECTIONAL STUDY

    Oct 1, 2018, 00:00

  • PND1 - REVIEW OF THE LISTED SIDE EFFECTS OF MYASTHENIA GRAVIS TREATMENTS VERSUS THOSE RECORDED IN PUBLICATIONS

    Oct 1, 2018, 00:00

  • PSY161 - A RAPID LITERATURE REVIEW OF REAL-WORLD EVIDENCE IN MULTIPLE MYELOMA- PATIENT CHARACTERISTICS AND HEALTH OUTCOMES

    Oct 1, 2018, 00:00

  • PMU118 - COGNITIVE DEBRIEFING INTERVIEW STUDIES TO INFORM PATIENT-REPORTED OUTCOME QUESTIONNAIRE DEVELOPMENT- A LITERATURE REVIEW AND SUGGESTED REPORTING GUIDELINES

    Oct 1, 2018, 00:00

  • PHP357 - MAKING SENSE FROM ANTI-SENSE- LESSONS IN TRANSLATING EXPEDITED REGULATORY APPROVAL INTO REIMBURSEMENT AND COMMERCIAL SUCCESS

    Oct 1, 2018, 00:00

  • PHP277 - HOW DO BELLWETHER HTA AGENCIES EVALUATE BIOSIMILARS?

    Oct 1, 2018, 00:00

  • PIN74 - A SYSTEMATIC REVIEW ON ECONOMIC EVALUATION OF ROTAVIRUS VACCINATION

    Oct 1, 2018, 00:00

  • HT2 - PATIENT CENTRIC MEASURES IN HTAS FOR AUTOIMMUNE DISEASES

    Oct 1, 2018, 00:00

  • PMD163 - HTA OF ARTIFICIAL URINARY SPHINCTER (AUS) FOR THE TREATMENT OF SEVERE MALE POST-PROSTATECTOMY INCONTINENCE IN ITALY

    Oct 1, 2018, 00:00

  • PSY149 - IQVIA PATIENT DATA ASSESSMENT- REAL WORLD EVIDENCE IN THE MANAGEMENT OF MODERATE-TO-SEVERE PLAQUE PSORIASIS

    Oct 1, 2018, 00:00

  • PDB51 - RESULTS OF THE COSMODIA STUDY- ESTIMATING THE IMPACT ON THE NUMBER OF CLINICAL COMPLICATIONS AND THE ASSOCIATED POTENTIAL FINANCIAL BENEFIT AS A CONSEQUENCE OF BETTER MANAGEMENT OF GLYCAEMIC CONTROL IN PEOPLE WITH TYPE 2 DIABETES IN ...

    Oct 1, 2018, 00:00

  • PSY170 - IMPACT OF MULTIPLE INDICATIONS ON PRICE AND ACCESS OF DRUGS FOR AUTOIMMUNE DISEASES

    Oct 1, 2018, 00:00

  • PMD146 - HEALTH CARE RESOURCE UTILIZATION AND COSTS AMONG PATIENTS WITH ASEPTIC LOOSENING AFTER PRIMARY TOTAL KNEE ARTHROPLASTY

    Oct 1, 2018, 00:00

  • PRM41 - ESTIMATION OF HOSPITAL COST SAVINGS ASSOCIATED WITH HYPOTENSION REDUCTION IN SEPTIC INTENSIVE CARE UNIT PATIENTS IN FRANCE

    Oct 1, 2018, 00:00

  • PCN322 - AN EXAMPLE OF RWE USED FOR HTA EVALUATION- ERLOTINIB RENEGOTIATION IN ITALY

    Oct 1, 2018, 00:00

  • PMH75 - PATIENT-REPORTED OUTCOMES IN PATIENTS WITH DEPRESSION- A QUALITATIVE STUDY

    Oct 1, 2018, 00:00

  • PHP330 - REAL-WORLD DATA COLLECTION ON MEDICAL DEVICES IN THE ERA OF VALUE-BASED HEALTHCARE- A LITERATURE REVIEW

    Oct 1, 2018, 00:00

  • PRM47 - UNDERSTANDING KEY VALUE DRIVERS OF A NOVEL TREATMENT IN MANAGEMENT OF FAMILIAL CHYLOMICRONEMIA SYNDROME

    Oct 1, 2018, 00:00

  • PDB42 - PRICE ANALYSIS OF ANTIDIABETIC DRUGS MARKETED IN ARABIC COUNTRIES

    Oct 1, 2018, 00:00

  • PHP142 - SEVERITY ADJUSTED PROBABILITY OF BEING COST-EFFECTIVE- A NOVEL APPROACH TO INTEGRATE SEVERITY AND COST-EFFECTIVENESS WITH APPLICATIONS TO NORWAY AND THE NETHERLANDS

    Oct 1, 2018, 00:00

  • PND41 - HEALTHCARE COSTS OF PATIENTS WITH SPINAL MUSCULAR ATROPHY

    Oct 1, 2018, 00:00

  • PMS29 - SECUKINUMAB VERSUS ADALIMUMAB IN THE TREATMENT OF ANKYLOSING SPONDYLITIS- A COST PER RESPONDER ANALYSIS AMONG 52 WEEKS FROM A TUNISIAN PERSPECTIVE.

    Oct 1, 2018, 00:00

  • PSY62 - DIRECT COST OFFSETS RELATED TO BELIMUMAB SUBCUTANEOUS ADMINISTRATION IN PATIENTS WITH SYSTEMIC LUPUS ERYTHEMATOSUS IN SPAIN

    Oct 1, 2018, 00:00

  • PP3 - TUNING INTO WHAT PATIENTS SAY ABOUT CLINICAL TRIALS WHEN SCIENTISTS AND CLINICIANS ARE NOT LISTENING- IMPLICATIONS FOR RECRUITMENT

    Oct 1, 2018, 00:00

  • PMU99 - PERCEPTIONS OF THE GREEK POPULATION CONCERNING MEDICINES – A DESCRIPTIVE ANALYSIS

    Oct 1, 2018, 00:00

  • PUK20 - COST-UTILITY ANALYSIS OF EXTRACORPOREAL LITHOTRIPSY VERSUS URETERORENOSCOPY-HOLMIUM LASER FOR TREATMENT OF URINARY STONES 20 MM.

    Oct 1, 2018, 00:00

  • PND84 - PATIENT AND CAREGIVER BURDEN OF BOTULINUM TOXIN A INJECTIONS

    Oct 1, 2018, 00:00

  • PHP147 - CHANGES IN THE NUMBER OF PHYSICIANS IN THE HEALTH CARE SYSTEM OF EUROPEAN COUNTRIES

    Oct 1, 2018, 00:00

  • PCN332 - REAL-WORLD USAGE OF BORTEZOMIB IN COMBINATION WITH THALIDOMIDE AND DEXAMETHASONE (VTD) AS FRONTLINE (FL) TREATMENT IN STEM CELL TRANSPLANT (SCT) ELIGIBLE MULTIPLE MYELOMA (MM) PATIENTS ACROSS EU5 COUNTRIES

    Oct 1, 2018, 00:00

  • PSS5 - VISION-RELATED QUALITY OF LIFE IN PATIENTS WITH DIABETIC MACULAR EDEMA TREATED WITH INTRAVITREAL AFLIBERCEPT- THE AQUA STUDY

    Oct 1, 2018, 00:00

  • PHP237 - OVERVIEW OF GERMAN AMNOG DOSSIERS WITH PRICE ANALYSIS BEFORE AND AFTER EARLY BENEFIT ASSESSMENT

    Oct 1, 2018, 00:00

  • PHP99 - OVER-THE-COUNTER MEDICINES USE AND ITS ASSOCIATION WITH RISK PERCEPTION AND SAFETY AMONG WOMEN VISITING COMMUNITY PHARMACIES IN MALAYSIA

    Oct 1, 2018, 00:00

  • PRM67 - UTILITIES IN ONCOLOGY SUBMISSIONS SUBMITTED TO NICE —APPROACH OF THE MANUFACTURERS

    Oct 1, 2018, 00:00

  • PND131 - PATIENT PREFERENCES FOR DIFFERENT MODES AND FREQUENCY OF ADMINISTRATION OF MULTIPLE SCLEROSIS DISEASE MODIFYING THERAPIES

    Oct 1, 2018, 00:00

  • PRM170 - UTILIZING PATIENT COLLAGES IN QUALITATIVE INTERVIEWS TO FACILITATE DATA COLLECTION IN PATIENTS DIAGNOSED WITH ULCERATIVE COLITIS

    Oct 1, 2018, 00:00

  • PCV144 - EFFECT OF CONVENIENCE OF ORAL ANTICOAGULANT THERAPY ON MEDICATION ADHERENCE- RESULTS OF AN INTERNATIONAL STATED PREFERENCE SURVEY

    Oct 1, 2018, 00:00

  • PDB1 - ACUTE RENAL OUTCOMES WITH SODIUM GLUCOSE CO-TRANSPORTER 2 INHIBITORS- REAL WORLD DATA ANALYSIS

    Oct 1, 2018, 00:00

  • PMD61 - COST EFFECTIVENESS OF DERMABOND PRINEO SKIN CLOSURE SYSTEM IN HIP AND KNEE ARTHROPLASTY IN TURKEY

    Oct 1, 2018, 00:00

  • PRM255 - QUANTIFYING SYSTEMATIC ERROR IN UNANCHORED INDIRECT COMPARISONS- THE IN-SAMPLE METHOD

    Oct 1, 2018, 00:00

  • PSY220 - IMPACT OF KERATOCONUS AND ITS TREATMENTS ON PATIENTS’ DAILY LIFE- QUALITATIVE PHASE OF THE DEVELOPMENT OF A QUALITY OF LIFE QUESTIONNAIRE

    Oct 1, 2018, 00:00

  • PND27 - COST IMPLICATIONS IN THE SELECTION OF FIRST LINE TREATMENT FOR HIGHLY ACTIVE RELAPSING MULTIPLE SCLEROSIS IN PORTUGAL

    Oct 1, 2018, 00:00

  • PHP100 - UTILIZATIONS AND EXPENDITURES OF TUMOR NECROSIS FACTOR ANTAGONISTS IN MEDICARE PART D- CROSS- SECTIONAL STUDY (2014-2015)

    Oct 1, 2018, 00:00

  • PHP240 - HEALTH TECHNOLOGY ASSESSMENTS OF BEVACIZUMAB BIOSIMILARS- COULD A DEMONSTRATION OF COST-EFFECTIVENESS CHANGE THE RECOMMENDATION FOR REIMBURSEMENT VERSUS THE ORIGINATOR?

    Oct 1, 2018, 00:00

  • PCV9 - VENOUS THROMBOEMBOLISM PROPHYLAXIS STRATEGIES FOR PEOPLE UNDERGOING ELECTIVE TOTAL KNEE REPLACEMENT- A SYSTEMATIC REVIEW AND NETWORK META-ANALYSIS TO INFORM NICE CLINICAL GUIDELINE RECOMMENDATION

    Oct 1, 2018, 00:00

  • PMS63 - COST-EFFECTIVENESS OF ACTONEL® 35 MG (RISEDRONATE) GASTRO-RESISTANT TABLETS FOR THE TREATMENT OF POSTMENOPAUSAL WOMEN WITH OSTEOPOROSIS IN FRANCE

    Oct 1, 2018, 00:00

  • PHP116 - TREND IN OPIOID USE FROM 2001 THROUGH 2013 AMONG ELDERLY US VETERANS

    Oct 1, 2018, 00:00

  • PUK10 - ANALYZING HEALTH-ECONOMIC EFFECTS OF A RENAL PRE-TRANSPLANT PATIENT-STRATIFICATION TOOL AT AN EARLY STAGE OF PRODUCT DEVELOPMENT

    Oct 1, 2018, 00:00

  • PRM175 - EQ-5D-3L VS. EQ-5D-5L- A CROSS-SECTIONAL COMPARISON OF MEASUREMENT PROPERTIES AMONG TOTAL HIP AND KNEE REPLACEMENT PATIENTS

    Oct 1, 2018, 00:00

  • PHP117 - TRENDS OF PRESCRIPTION FOR OFF-LABEL DRUGS IN KOREAN PEDIATRIC PATIENTS USING CLAIMS DATA- WITH A FOCUS ON CLINICAL AREAS AND PRIMARY DISEASES

    Oct 1, 2018, 00:00

  • PRM77 - VALIDATION OF COPD ICD10 DIAGNOSTIC CODES IN THE SIDIAP PRIMARY HEALTH CARE RESEARCH DATABASE USING A COMBINATION OF SPIROMETRY MEASURES, SYMPTOMS, DRUG USE, AND FREE TEXT REVIEW.

    Oct 1, 2018, 00:00

  • PMU45 - ESTIMATING THE CLINICAL AND ECONOMIC BURDEN OF HYPERKALAEMIA IN PATIENTS WITH CHRONIC KIDNEY DISEASE OR HEART FAILURE

    Oct 1, 2018, 00:00

  • PCV68 - POTENTIAL SAVINGS IN HIGHEST PRESCRIBING REGIONS FOR DIRECT-ACTING ORAL ANTICOAGULANTS IN ENGLAND

    Oct 1, 2018, 00:00

  • PCV35 - SECONDARY PREVENTION FOR CARDIOVASCULAR DISEASE- DEFINITION OF POPULATION AND EVALUATION OF OUTCOMES USING REAL WORLD DATA

    Oct 1, 2018, 00:00

  • PMD83 - CERVICAL CANCER SCREENING IN EUROPE - A SYSTEMATIC REVIEW ON COST EFFECTIVENESS STUDIES WITH SPECIFIC INTEREST ON RISK-ADAPTED STRATEGIES

    Oct 1, 2018, 00:00

  • PRM5 - PROFILING OF DISEASE SYMPTOMS AND ADVERSE EVENTS- DOES SOCIAL MEDIA AUGMENT TRADITIONAL APPROACHES?

    Oct 1, 2018, 00:00

  • PHP81 - COMPARISON OF SELECTED DRUGS PRICES IN EU COUNTRIES

    Oct 1, 2018, 00:00

  • AD4 - ARE PATIENT-REPORTED PERSISTENCE AND ADHERENCE TO TREATMENT FOR A CHRONIC DISEASE VALID OUTCOMES? AN EXAMPLE WITH OSTEOPOROSIS

    Oct 1, 2018, 00:00

  • PIN8 - COMPARATIVE EFFICACY OF FIDAXOMICIN, VANCOMYCIN AND METRONIDAZOLE FOR THE TREATMENT OF CLOSTRIDIUM DIFFICILE INFECTION- A NETWORK META-ANALYSIS

    Oct 1, 2018, 00:00

  • PCV23 - TIME TO TREATMENT INTENSIFICATION IN NEW STATIN USERS

    Oct 1, 2018, 00:00

  • PSY187 - THE QUANTITY AND QUALITY OF EVIDENCE SUPPORTING EUROPEAN MARKETING AUTHORISATION OF ORPHAN DRUGS- COMPARISON OF RARE ONCOLOGY VERSUS RARE DISEASE

    Oct 1, 2018, 00:00

  • PSY143 - EPIDEMIOLOGY AND TREATMENT OF MICROSCOPIC COLITIS – REAL WORLD EVIDENCE FROM THE CZECH REPUBLIC

    Oct 1, 2018, 00:00

  • PND33 - PAYER AND SOCIETAL BENEFIT OF PEGINTERFERON BETA-1A VERSUS GLATIRAMER ACETATE IN PATIENTS WITH RELAPSING-REMITTING MULTIPLE SCLEROSIS IN ITALY

    Oct 1, 2018, 00:00

  • PCN53 - STRUCTURED LITERATURE REVIEW OF THE PREVALENCE OF MICROSATELLITE INSTABILITY HIGH (MSI-H) AND DEFICIENT MISMATCH REPAIR (DMMR) AMONG SOLID TUMORS

    Oct 1, 2018, 00:00

  • PCN180 - PHARMACOECONOMIC ASSESSMENT OF FULVESTRANT VERSUS DD (DOXORUBICIN, DOCETAXEL) THERAPY IN POSTMENOPAUSAL WOMEN WITH METASTATIC ER (+) HER2 (-) BREAST CANCER IN UKRAINE

    Oct 1, 2018, 00:00

  • PCN223 - WHAT UNDERLIES THE OBSERVED HOSPITAL VOLUME-OUTCOME RELATIONSHIP?

    Oct 1, 2018, 00:00

  • PHP105 - A POPULATION-BASED DATA ANALYSIS OF DRUG PRESCRIPTION AND PATTERNS OF USE OF ANTIBIOTIC IN SOUTHERN ITALY POPULATION

    Oct 1, 2018, 00:00

  • PCN217 - KEEPING UP WITH THE COMPARATORS- TRENDS IN TARGETED CANCER THERAPIES BECOMING RIGHT COMPARATORS FOR PAYERS

    Oct 1, 2018, 00:00

  • PHP232 - A COMPARISON OF COST-EFFECTIVENESS ASSESSMENTS BETWEEN NICE AND SMC TECHNOLOGY APPRAISALS

    Oct 1, 2018, 00:00

  • PND35 - HEALTHCARE, SICKNESS ABSENCE, AND DISABILITY PENSION COST TRAJECTORIES IN FIVE YEARS FOLLOWING MS DIAGNOSIS- REGISTER-BASED PROSPECTIVE COHORT STUDIES IN SWEDEN

    Oct 1, 2018, 00:00

  • PHP135 - CHANGES IN THE NUMBER OF DENTISTS IN EUROPEAN COUNTRIES BETWEEN 2000-2015

    Oct 1, 2018, 00:00

  • PCN227 - ACCESS TO ESSENTIAL ANTINEOPLASTICS AND IMMUNOSUPPRESSIVES

    Oct 1, 2018, 00:00

  • PMS56 - COST-EFFECTIVENESS ANALYSIS OF SUBCUTANEOUS TOCILIZUMAB WITHOUT METHOTREXATE IN RHEUMATOID ARTHRITIS TREATMENT

    Oct 1, 2018, 00:00

  • PCV107 - MULTI-CRITERIA DECISION ANALYSIS (MCDA) - DISCUSSION ABOUT THE INCORPORATION OF RIOCIGUAT IN THE TREATMENT OF CHRONIC THROMBOEMBOLIC PULMONARY HYPERTENSION (CTEPH) UNDER THE PERSPECTIVE OF BRAZILIAN PUBLIC HEALTHCARE SYSTEM (SUS)

    Oct 1, 2018, 00:00

  • PCN226 - BIOSIMILARS AND THE REGULATION OF ONCOLOGICAL PREPARATIONS IN GERMANY

    Oct 1, 2018, 00:00

  • PMS14 - CHILDHOOD OBESITY AND FRACTURE RISK- A REGION-WIDE LONGITUDINAL COHORT STUDY OF 466,000 CHILDREN AND UP TO 11 YEARS OF FOLLOW-UP

    Oct 1, 2018, 00:00

  • PND144 - REPORTED QUALITY OF LIFE IN PEOPLE WITH MULTIPLE SCLEROSIS UNDER LONG TERM TREATMENT WITH FAMPRIDINE

    Oct 1, 2018, 00:00

  • QL1 - VALIDATION OF PROMIS PREFERENCE SCORE (PROPR) IN GERMAN PATIENTS WITH RHEUMATOLOGICAL CONDITIONS

    Oct 1, 2018, 00:00

  • PMD81 - COST EFFECTIVENESS ANALYSIS OF MAGNETIC RESONANCE-GUIDED FOCUSED ULTRASOUND FOR REFRACTORY PAINFUL BONE METASTASES

    Oct 1, 2018, 00:00

  • PMU1 - FREQUENCY OF REPORTABLE ADVERSE EVENTS IN HEALTH-RELATED SOCIAL MEDIA POSTS

    Oct 1, 2018, 00:00

  • PHP145 - NUMBER OF PHARMACISTS IN EUROPEAN COUNTRIES BETWEEN 2000-2015

    Oct 1, 2018, 00:00

  • PRS49 - COST-EFFECTIVENESS OF THE FIXED-DOSE COMBINATION TIOTROPIUM + OLODATEROL VERSUS TIOTROPIUM BASED ON THE DYNAGITO TRIAL RESULTS IN FRANCE

    Oct 1, 2018, 00:00

  • PHP206 - TUMOUR-AGNOSTIC AGENTS- ARE THEY FIT FOR REIMBURSEMENT?

    Oct 1, 2018, 00:00

  • PCV92 - EARLY HEALTH TECHNOLOGY ASSESSMENT OF TISSUE-ENGINEERED HEART VALVES IN THE AORTIC POSITION IN ELDERLY PATIENTS

    Oct 1, 2018, 00:00

  • PCN74 - A BUDGET-IMPACT ANALYSIS OF ADJUVANT PERTUZUMAB AND TRASTUZUMAB IN EARLY HER2-POSITIVE BREAST CANCER

    Oct 1, 2018, 00:00

  • PCP70 - REGENERATIVE MEDICINE- A PROPOSED CLASSIFICATION FOR HEOR BASED ON THERAPEUTIC STRATEGY AND TECHNOLOGY TYPE

    Oct 1, 2018, 00:00

  • PSY114 - COST-EFFECTIVENESS OF VEDOLIZUMAB COMPARED WITH CONVENTIONAL THERAPY IN PATIENTS WITH CROHN’S DISEASE IN THE UNITED KINGDOM (UK)

    Oct 1, 2018, 00:00

  • PMH20 - BUDGETARY IMPACT OF TREATING OPIOID ADDICTION IN THE DANISH MUNICIPAL SETTING

    Oct 1, 2018, 00:00

  • PCN261 - A REAL-WORLD DATA STUDY REGARDING HOSPITAL RESOURCES USE AND COSTS ASSOCIATED WITH COLORECTAL CANCER IN SPAIN

    Oct 1, 2018, 00:00

  • PIN97 - VALIDATING DATA ON HEPATITIS C TESTING IN THE UK IN THE PRIMARY CARE SETTING

    Oct 1, 2018, 00:00

  • PSS36 - PHARMACOECONOMIC EVALUATION OF PHARMACOLOGICAL TREATMENT OPTIONS FOR PATIENTS WITH MODERATELY-SEVERE AND SEVERE PSORIASIS WITH BASE THERAPY RESISTANCE

    Oct 1, 2018, 00:00

  • PUK36 - COMPARISON OF PATIENT-REPORTED OUTCOMES IN RANDOMIZED CONTROLLED TRIALS AND IN OBSERVATIONAL STUDIES FOR OVERACTIVE BLADDER- A SYSTEMATIC LITERATURE REVIEW

    Oct 1, 2018, 00:00

  • CP1 - MULTI-INDICATION THERAPIES- DEVELOPING A VALUE-BASED FRAMEWORK TO INCORPORATE OPPORTUNITY COST

    Oct 1, 2018, 00:00

  • PDB111 - TREND AND FACTORS ASSOCIATED WITH PREVENTABLE HOSPITALIZATION AMONG DIABETES MELLITUS PATIENTS IN A NATIONAL HEALTH INSURANCE PROGRAM

    Oct 1, 2018, 00:00

  • PMU35 - COST COMPARISON OF COMPLEMENTARY AND ALTERNATIVE MEDICINE SPECIALIZED UNIT IN SUS

    Oct 1, 2018, 00:00

  • PRM217 - THE ONLINE VERSION OF EMPRO- A NEW PLATFORM SYSTEM FOR THE STANDARDIZED APPRAISAL OF PRO INSTRUMENTS.

    Oct 1, 2018, 00:00

  • PCN368 - CONCORDANCE BETWEEN PATIENTS AND CLINICIANS’ REPORTING OF SYMPTOMATIC ADVERSE EVENTS IN CANCER CLINICAL TRIALS- A SYSTEMATIC REVIEW

    Oct 1, 2018, 00:00

  • PDB67 - ONCE-WEEKLY SEMAGLUTIDE VERSUS DULAGLUTIDE FOR THE TREATMENT OF PATIENTS WITH TYPE 2 DIABETES IN PORTUGAL- A LONG-TERM COST-EFFECTIVENESS ANALYSIS BASED ON SUSTAIN 7

    Oct 1, 2018, 00:00

  • PND132 - ECONOMIC BURDEN OF MIGRAINE IN BRAZIL- RESULTS FROM MY MIGRAINE VOICE SURVEY

    Oct 1, 2018, 00:00

  • PMH11 - E-THERAPIES IN PREVENTING AND TREATING EATING DISORDERS- REVIEW OF TRIALS AND REAL-WORLD EVIDENCE

    Oct 1, 2018, 00:00

  • PMH2 - EXAMINING PARKINSON’S DISEASE PSYCHOSIS TREATMENT OUTCOMES IN THE REAL WORLD- THE INSYTE OBSERVATIONAL STUDY – INITIAL YEAR 1 INTERIM FINDINGS

    Oct 1, 2018, 00:00

  • PUK3 - STUDY OF DIABETIC NEPHROPATHY PREVALENCE AMONG TYPE 2 DIABETIC OUTPATIENTS WITH UNCONTROLLED GLYCEMIA

    Oct 1, 2018, 00:00

  • PMD140 - OUT-OF-POCKET PAYMENTS FOR MEDICAL DEVICES AND EQUITY IN HEALTHCARE FOR PATIENTS WITH PRIMARY LYMPHEDEMA IN FRANCE

    Oct 1, 2018, 00:00

  • PSY54 - BUDGET IMPACT ANALYSIS OF NINTEDANIB IN IDIOPATHIC PULMONARY FIBROSIS IN TURKEY

    Oct 1, 2018, 00:00

  • PRM80 - THE USE OF EXTERNAL DATA TO BETTER INFORM SURVIVAL EXTRAPOLATIONS IN SUBMISSIONS TO THE NATIONAL INSTITUTE FOR HEALTH AND CARE EXCELLENCE (NICE)

    Oct 1, 2018, 00:00

  • PRM129 - DECISION ANALYTIC MODELS TO INFORM ABOUT THE OPTIMAL MAMMOGRAPHY SCREENING INTERVALS- A SYSTEMATIC REVIEW.

    Oct 1, 2018, 00:00

  • PHP278 - GUIDELINES IN GERMAN EARLY BENEFIT ASSESSMENT – WHICH GUIDELINES ARE CONSIDERED BY FEDERAL JOINT COMMITTEE FOR DETERMINING THE APPROPRIATE COMPARATOR?

    Oct 1, 2018, 00:00

  • PIN34 - COMPARING THE ESTIMATED PUBLIC HEALTH IMPACT AND COST-EFFECTIVENESS OF PHID-CV AND PCV-13 IN THE ROUTINE IMMUNISATION PROGRAMME IN GAVI-ELIGIBLE COUNTRIES (SUB-SAHARAN AFRICA AND ASIA/OCEANIA)- A MODELLING STUDY

    Oct 1, 2018, 00:00

  • PSY29 - REAL-WORLD DISCONTINUATION OF BIOLOGICAL TREATMENTS IN MODERATE-TO-SEVERE PLAQUE PSORIASIS OVER THE FIRST 5 YEARS OF TREATMENT – A LITERATURE REVIEW OF DRUG SURVIVAL

    Oct 1, 2018, 00:00

  • PHP12 - PATIENTS’ RELATED ISSUES ARISING FROM TARGET PRODUCT PROFILE, PRODUCT DEVELOPMENT PLAN AND IN THE DESIGN OF CLINICAL TRIALS

    Oct 1, 2018, 00:00

  • PCN249 - CHEMOTHERAPY-INDUCED NAUSEA AND VOMITING (CINV) AND DRIVERS OF ANTIEMETIC PRESCRIBING- RESULTS OF A QUALITATIVE IN-PRACTICE STUDY OF CLINICIANS FROM VARIOUS SETTINGS

    Oct 1, 2018, 00:00

  • PHP274 - ITALY’S NEW PHARMACEUTICAL INNOVATION RANKING SYSTEM- KEY CRITERIA FOR SUCCESSFULLY ACHIEVING INNOVATIVE STATUS

    Oct 1, 2018, 00:00

  • PCP46 - A SIMPLE DECISION TREE TO IDENTIFY POTENTIAL APPLICATIONS OF MACHINE LEARNING AS AN ADDITION TO TRADITIONAL STATISTICAL ANALYSIS IN HEALTH ECONOMICS AND OUTCOMES RESEARCH

    Oct 1, 2018, 00:00

  • PCP62 - MARKET ACCESS UNDER AGILE CIRCUMSTANCES

    Oct 1, 2018, 00:00

  • PCN266 - A REAL-WORLD DATA STUDY REGARDING HOSPITAL RESOURCES USE AND COSTS ASSOCIATED WITH BLADDER CANCER IN SPAIN

    Oct 1, 2018, 00:00

  • PIN119 - THERAPEUTIC SEQUENCES FOR THE TREATMENT OF PEOPLE LIVING WITH HIV TYPE 1 IN PORTUGAL

    Oct 1, 2018, 00:00

  • PDB15 - CARDIOVASCULAR SAFETY OF EMPAGLIFLOZIN VERSUS DIPEPTIDYL PEPTIDASE 4 (DPP-4) INHIBITORS- SYSTEMATIC LITERATURE REVIEW AND INDIRECT COMPARISONS

    Oct 1, 2018, 00:00

  • PCP1 - COMPARISON OF THE GERMAN MIXED PRICE MODEL AND INDICATION-SPECIFIC PRICING FOR MULTI-INDICATION PRODUCTS IN ONCOLOGY

    Oct 1, 2018, 00:00

  • PDB62 - COST-EFFECTIVENESS ANALYSIS OF EMPAGLIFLOZIN IN JAPAN BASED ON RESULTS FROM THE SUBGROUP ANALYSIS OF ASIAN PATIENTS IN THE EMPA-REG OUTCOME TRIAL

    Oct 1, 2018, 00:00

  • PRM133 - ESTIMATED COST SAVINGS FROM DOSE BANDING GUIDANCE- A CASE STUDY USING TREATMENTS FOR STAGE IV MELANOMA

    Oct 1, 2018, 00:00

  • PMD110 - COST-EFFECTIVENESS OF IMMUNOADSORPTION FOR INCOMPATIBLE KIDNEY TRANSPLANTATION IN GERMANY

    Oct 1, 2018, 00:00

  • PHP44 - EXPLORING THE KNOWLEDGE AND PERCEPTION OF GENERIC MEDICINE USE AMONG COMMUNITY PHARMACISTS IN SAUDI ARABIA

    Oct 1, 2018, 00:00

  • PDB29 - TYPE 2 DIABETES- DISCONTINUATION OF ANTIDIABETIC DRUG DISPENSING 8 YEARS AFTER STARTING TREATMENT- A NATIONWIDE COHORT STUDY USING THE FRENCH NATIONAL HEALTH DATA SYSTEM (SNDS)

    Oct 1, 2018, 00:00

  • PRS5 - IDENTIFICATION AND ESTIMATION OF THE PREVALENCE OF ACUTE SEVERE ASTHMA IN FRANCE USING THE EGB CLAIM DATABASE

    Oct 1, 2018, 00:00

  • PCN137 - THE ECONOMIC EVALUATION OF IMATINIB COMBINED WITH CHEMOTHERAPY FOR PEDIATRIC PHILADELPHIA CHROMOSOME-POSITIVE ACUTE LYMPHOBLASTIC LEUKEMIA IN CHINA

    Oct 1, 2018, 00:00

  • PMD115 - THE DIAGNOSTIC METHODS AND COST OF LUNG CANCER IN GREECE

    Oct 1, 2018, 00:00

  • PDB132 - TYPE 2 DIABETES TREATMENT PATHS AND PATIENT OUTCOMES IN RESPONSE TO REIMBURSEMENT POLICY CHANGE IN FINLAND

    Oct 1, 2018, 00:00

  • Systematic Review and Network Meta-Analysis of Treatments for Chemotherapy-Naive Patients with Asymptomatic/Mildly Symptomatic Metastatic Castration-Resistant Prostate Cancer

    Oct 1, 2018, 00:00

  • PRM172 - LEARNINGS ON BRING YOUR OWN DEVICE UPTAKE FOR ECOA IMPLEMENTATION- A TALE OF TWO STUDIES

    Oct 1, 2018, 00:00

  • PIN126 - THE QUALITY OF LIFE (QOL) LOSS ASSOCIATED WITH INVASIVE MENNINGOCOCCAL B DISEASE (MENB) IN GERMANY

    Oct 1, 2018, 00:00

  • PHP163 - THE FRENCH HEALTH ECONOMIC RESEARCH PROGRAM(PRME)- AN OVERVIEW SINCE ITS CREATION IN 2013

    Oct 1, 2018, 00:00

  • PMD85 - INDIRECT COMPARISON AND COST-EFFECTIVENESS ANALYSIS OF MINIMALLY INVASIVE ENDOVENOUS CYANOACRYLATE GLUE OCCLUSION, SURGICAL AND OTHER TREATMENT OPTIONS IN CHRONIC VENOUS INSUFFICIENCY

    Oct 1, 2018, 00:00

  • PHP287 - GERMAN EARLY BENEFIT ASSESSMENTS OF ORPHAN DRUGS UNDER FULL DOSSIER CONDITIONS

    Oct 1, 2018, 00:00

  • PHP273 - A REVIEW OF ISSUES AFFECTING THE EFFICIENCY OF DECISION MAKING IN THE NICE SINGLE TECHNOLOGY APPRAISAL PROCESS

    Oct 1, 2018, 00:00

  • PCV70 - EFFECT OF TIME IN THERAPEUTIC RANGE ON COST AND CLINICAL OUTCOMES OF ATRIAL FIBRILATION PATIENTS - A COST-CONSEQUENCES ANALYSIS OF RIVAROXABAN VS WARFARIN FOR TURKEY

    Oct 1, 2018, 00:00

  • PSY213 - WHAT MATTERS TO INDIVIDUALS WITH SICKLE CELL DISEASE? PATIENT INPUT ON THE RELEVANT AND IMPORTANT SYMPTOMS AND IMPACTS OF THE CONDITION

    Oct 1, 2018, 00:00

  • PSS52 - THE BURDEN IN DIABETIC MACULAR EDEMA IN KOREA

    Oct 1, 2018, 00:00

  • PND120 - TREATMENT DECISIONS ABOUT FIRST-LINE DISEASE-MODIFYING TREATMENTS (DMTS) IN RELAPSING REMITTING MULTIPLE SCLEROSIS- A SYSTEMATIC REVIEW OF PATIENT NEEDS AND PREFERENCES

    Oct 1, 2018, 00:00

  • DS4 - A MULTI-DATABASE, MULTINATIONAL VALIDATION STUDY OF CARDIOVASCULAR DEATH, VENOUS THROMBOEMBOLIC EVENTS AND GASTROINTESTINAL DISEASES IN THE EU-ADR ALLIANCE

    Oct 1, 2018, 00:00

  • PHP85 - THE RISE OF THE NON-SUBMISSION – A WORRYING TREND FOR UK PATIENT ACCESS WITH ‘BREXIT’ APPROACHING

    Oct 1, 2018, 00:00

  • PCV121 - PERFORMANCE INDICATORS OF CARDIAC REHABILITATION IN HUNGARY

    Oct 1, 2018, 00:00

  • PSY184 - HTA AND REIMBURSEMENT CONSIDERATIONS FOR RARE DISEASES IN EUROPEAN MARKETS- WHAT ARE THE IMPLICATIONS FOR MANUFACTURERS?S?

    Oct 1, 2018, 00:00

  • PIH40 - THE HEALTH LITERACY OF IRANIAN PARENTS- A SURVEY IN TEHRAN CAPITAL CITY

    Oct 1, 2018, 00:00

  • PIN25 - PROJECTED BURDEN OF VACCINE-PREVENTABLE DISEASES IN OLDER ADULTS IN THE UNITED STATES- IMPACT OF POPULATION AGING

    Oct 1, 2018, 00:00

  • PMS69 - BIOSIMILAR AND ORIGINATOR INFLIXIMAB- INFLUENCE OF LOCAL POLICY MEASURES AND PRACTICES ON MARKET DYNAMICS BETWEEN SWEDISH COUNTIES

    Oct 1, 2018, 00:00

  • PGI11 - HIGH LEVELS OF REIMBURSED COST AND USE OF GASTROENTEROLOGICAL DRUGS IN FRANCE

    Oct 1, 2018, 00:00

  • PSY77 - ASSESSING THE IMPACT OF FORTIFYING PACKAGED INFANT CEREALS IN REDUCING THE BURDEN OF IRON DEFICIENCY ANEMIA IN PAKISTAN

    Oct 1, 2018, 00:00

  • PCN248 - USE OF CANCER DRUGS IN THE END-OF-LIFE IN MEN DYING OF CASTRATION-RESISTANT PROSTATE CANCER- POPULATION-BASED STUDY

    Oct 1, 2018, 00:00

  • PRM145 - A NEW GRAPHICAL REPRESENTATION OF PROBABILITY SENSITIVITY ANALYSIS RESULTS AS AN ALTERNATIVE FOR THE SCATTER-PLOT

    Oct 1, 2018, 00:00

  • PMU22 - ANTICHOLINERGIC BURDEN IN OLDER PATIENTS- PHARMACIST INTERVENTION

    Oct 1, 2018, 00:00

  • PSY180 - UK HEALTH TECHNOLOGY ASSESSMENT OF ORPHAN DRUGS FOR RARE ONCOLOGY VERSUS RARE DISEASE- DOES ORPHAN DESIGNATION MAKE ANY DIFFERENCE IN HTA PROCESS?

    Oct 1, 2018, 00:00
  • «
  • 51
  • 52
  • 53
  • 54
  • 55
  • 56
  • 57
  • 58
  • 59 (current)
  • 60
  • »